Detection of alpha-1 antitrypsin deficiency: the past, present and future

Most patients with alpha-1 antitrypsin deficiency remain undiagnosed and therefore do not benefit from current therapies or become eligible for research studies of new treatments under development. Improving t...

Source: Orphanet Journal of Rare Diseases - April 19, 2020 Category: Internal Medicine Authors: Mark Brantly, Michael Campos, Angela M. Davis, Jeanine D ’Armiento, Kenneth Goodman, Kathi Hanna, Miriam O’Day, John Queenan, Robert Sandhaus, James Stoller, Charlie Strange, Jeffrey Teckman and Adam Wanner Tags: Review Source Type: research